Please use this identifier to cite or link to this item:
http://111.93.178.142:25000/jspui/handle/123456789/5534Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Simi Bridijit Gomaz | - |
| dc.date.accessioned | 2026-07-02T08:37:06Z | - |
| dc.date.available | 2026-07-02T08:37:06Z | - |
| dc.date.issued | 2026-07-02 | - |
| dc.identifier.uri | http://111.93.178.142:25000/jspui/handle/123456789/5534 | - |
| dc.description | Vol. 163, No. 1, p 41 | en_US |
| dc.language.iso | en | en_US |
| dc.subject | Antihypertensive agents | en_US |
| dc.subject | Diabetes mellitus | en_US |
| dc.subject | Endothelin - 1 | en_US |
| dc.subject | Hypertension | en_US |
| dc.subject | Insulin resiatance | en_US |
| dc.title | Telmisartan vs. other antihypartensives on cardioetabolic and vascular outcomes in diabetic hypertension : A randomised trial | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Vol. 163, No. 1, 2026 | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.